EUVIMEDEUVIMED entdecken
Crossref

The Transition of Blood Biomarkers During 96-Week Treatment with Upadacitinib for Atopic Dermatitis: A Real-World Analysis Stratified by Age

Teppei Hagino iD, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

Dermatitis® · 2026

DOI: 10.1089/derm.2025.0034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dermatitis®, 2026. Verfasst von Teppei Hagino und 3 weiteren Autor:innen. Beteiligte Einrichtung: From the, Department of Dermatology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Heterocyclic Compounds, 3-Ring. Die Arbeit nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The transition of laboratory indexes is unknown for long-term (2-year) upadacitinib treatment in atopic dermatitis (AD).

Objective

To assess the 96-week real-world effects of upadacitinib on the transition of immunoglobulin E (IgE), thymus and activation-regulated chemokine (TARC), lactate dehydrogenase (LDH), and total eosinophil count (TEC) in Japanese patients with AD, stratified by age groups (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicHeterocyclic Compounds, 3-RingHumansBiomarkersFemaleMaleProspective StudiesAdultMiddle AgedImmunoglobulin EAdolescentChemokine CCL17AgedL-Lactate DehydrogenaseYoung AdultAge FactorsEosinophilsLeukocyte CountSeverity of Illness Index

Substanzen

BiomarkersImmunoglobulin EChemokine CCL17upadacitinibHeterocyclic Compounds, 3-RingL-Lactate DehydrogenaseCCL17 protein, human

Autor:innen und Institutionen

  • From the, Department of Dermatology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan.
  • Department of Dermatology, Nippon Medical School, Tokyo, Japan.
  • Fujimoto Dermatology Clinic, Funabashi, Japan.

ORCID-Profile: Teppei Hagino

Zitieren

APA

Hagino, T., Saeki, H., Fujimoto, E., & Kanda, N. (2026). The Transition of Blood Biomarkers During 96-Week Treatment with Upadacitinib for Atopic Dermatitis: A Real-World Analysis Stratified by Age. Dermatitis®. https://doi.org/10.1089/derm.2025.0034

Vancouver

Hagino T, Saeki H, Fujimoto E, Kanda N. The Transition of Blood Biomarkers During 96-Week Treatment with Upadacitinib for Atopic Dermatitis: A Real-World Analysis Stratified by Age. Dermatitis®. 2026. doi:10.1089/derm.2025.0034

BibTeX
@article{Hagino2026,
  author = {Hagino, Teppei and Saeki, Hidehisa and Fujimoto, Eita and Kanda, Naoko},
  title = {The Transition of Blood Biomarkers During 96-Week Treatment with Upadacitinib for Atopic Dermatitis: A Real-World Analysis Stratified by Age},
  journal = {Dermatitis®},
  year = {2026},
  doi = {10.1089/derm.2025.0034}
}
Kostenlos starten →